Table 1.
Schedule of assessments in a prespecified subset of patients for PV durability and safety
| Pre-procedure (<72 h) | Post-procedure (<72 h) | 1 month | 3 months | |
|---|---|---|---|---|
| 3D electroanatomic remap (n = 30) | Xa | |||
| Cardiac CT/MRA (n = 30) | X | |||
| EE (n = 31) | Xb | |||
| Neurological assessments (n = 30) | ||||
| Cerebral MRI | X | X | Xc | Xc |
| Neurological examination | X | X | Xc | Xc |
| NIHSS | X | X | Xc | Xc |
| mRS | X | X | Xc | |
| MMSE | X | X | Xc |
3D, three-dimensional; CT, computed tomography; EE, oesophageal endoscopy MMSE, mini mental state examination; MRA, magnetic resonance angiogram; MRI, magnetic resonance imaging; mRS, modified rankin scale; NIHSS, national institutes of health stroke scale; PV, pulmonary vein.
a75 days post-procedure (±15 days).
bBetween 1 and 3 days (72 h) post-procedure.
cPerformed if neurological symptoms and/or cerebral ischaemic lesions were identified in a prior evaluation.